Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology

With recent advances, chimeric antigen receptor (CAR) immunotherapy has become a promising modality for patients with refractory cancer diseases. The successful results of CAR T cell therapy in relapsed and refractory B-cell malignancies shifted the paradigm of cancer immunotherapy by awakening the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Hyeon Joo, Harapan, Biyan Nathanael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580929/
https://www.ncbi.nlm.nih.gov/pubmed/34554405
http://dx.doi.org/10.1007/s12026-021-09236-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580929/
https://www.ncbi.nlm.nih.gov/pubmed/34554405
http://dx.doi.org/10.1007/s12026-021-09236-x

Ejemplares similares